| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.2M | -27.6% |
| Cost of Revenue | $26.4M | -23.6% |
| Gross Profit | $1.07B | — |
| R&D Expense | $799K | -86.6% |
| SG&A Expense | $5.7M | — |
| Operating Income | -$7.7M | +26.1% |
| Pre-tax Income | -$8.7M | +9.4% |
| Income Tax | $35K | -44.4% |
| Net Income | -$8.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -8.0% |
| Accounts Receivable | $3.6M | -35.7% |
| Current Assets | $5.7M | -27.0% |
| Total Assets | $6.9M | -67.0% |
| Current Liabilities | $7.7M | +24.5% |
| Total Liabilities | $8.2M | -1.5% |
| Stockholders' Equity | -$1.4M | -111.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | +17.3% |
| Capital Expenditures | $12K | -70.0% |
| Investing Cash Flow | -$12K | +99.6% |
| Financing Cash Flow | $2.1M | -62.6% |
| Free Cash Flow | -$2.2M | +18.1% |
| +9.6% |
| EPS (Basic) | -$2.08 | +20.9% |
| EPS (Diluted) | -$2.08 | +20.9% |